Exergen Medical Assists Identifying Fevers in Children – Exergen Temporal Scanner

Nurses are on the frontline of patient care and it's always been the mission of Exergen – creators of the Exergen Temporal Scanner – to support their work and help make their jobs easier and more effective. More than a billion temperatures are taken a year and every nurse needs the best temporal thermometer they can rely on to get the most accurate, quickest and convenient reading – every single time. Click here to read the full article.

By |2019-03-12T15:12:09+00:00January 30th, 2019|News|Comments Off on Exergen Medical Assists Identifying Fevers in Children – Exergen Temporal Scanner
  • aquent

AQUENT AND CAPITAL ONE PARTNER TO CREATE PRO BONO INITIATIVE

Aquent and Capital One are excited to announce the launch of Four Good – a pro bono initiative and quarterly event series that will provide creative services to nonprofits in Chicago. Four Good is a quarterly meetup that will host Chicago creatives to rally around one goal: to solve a creative issue for a local non-profit within a 4-hour time frame. The creative services Four Good can provide range from logo and webpage design, to social media strategy and overall [...]

By |2019-02-19T15:41:47+00:00January 30th, 2019|News|Comments Off on AQUENT AND CAPITAL ONE PARTNER TO CREATE PRO BONO INITIATIVE
  • Exergen

Exergen Global introduces PEKO thermal dynamic management solution

WATERTOWN, MA and ZIJTAART, the Netherlands-Exergen Global has announced the industry’s only noncontact thermal dynamic management solution to combine a proprietary-design cooling mechanism with a unique emissivity control device to provide accurate, repeatable thermal measurement results in industrial settings under extreme conditions, with ambient temperatures as high as 500oC. Click here to read the full article.

By |2019-03-12T18:50:45+00:00January 25th, 2019|News|Comments Off on Exergen Global introduces PEKO thermal dynamic management solution
  • organogenesis

Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, will sponsor a January 30 WoundSource webinar, "Chronic Wounds and Biofilms: Advancing Assessment and Treatment" led by Gregory Schultz, PhD, Professor of Obstetrics and Gynecology and Director of the Institute for Wound Research at the University of Florida. Click here to read the full article.

By |2020-02-13T18:49:31+00:00January 24th, 2019|News|Comments Off on Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz

The Time Obsessed Consumer: Study Reveals Impact on Brands Now that Time is the New Currency

Allen & Gerritsen survey shows that to today’s consumer, the relationship between time and money is more complicated than ever. Taking a look at consumer's relationship with time, which is more fleeting than ever, especially in light of technology designed to make lives easier. Click here to read the full article.

By |2019-02-19T15:28:13+00:00January 18th, 2019|News|Comments Off on The Time Obsessed Consumer: Study Reveals Impact on Brands Now that Time is the New Currency
  • organogenesis

Organogenesis Holdings Inc. Receives Positive Nasdaq Listing Determination

Class A Common Stock to Resume Trading on Nasdaq Organogenesis Holdings Inc. (the "Company") (Nasdaq: ORGO; ORGOW) today announced that on January 4, 2019, the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq") that, based on the plan of compliance presented by the Company at its hearing, the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for the continued listing of its Class A common stock on The Nasdaq Capital Market. Pursuant to the Panel's decision, on [...]

By |2020-02-13T18:50:30+00:00January 7th, 2019|News|Comments Off on Organogenesis Holdings Inc. Receives Positive Nasdaq Listing Determination
  • Exergen

Exergen Reduces Hospital Costs by 90%

Exergen Corporation has announced that two new studies from Postgraduate Medical Journal indicate that when used throughout a hospital, Exergen TemporalScanners deliver substantial cost savings while providing accuracy and ease of use, as supported by more than 70 peer-reviewed published studies for all ages and clinical settings. Click here to read the full article.

By |2019-03-12T19:53:20+00:00December 28th, 2018|News|Comments Off on Exergen Reduces Hospital Costs by 90%
  • Exergen

Exergen’s Sensors Help Develop A Solution To Ensure Safe Blood Transfusions

Exergen Global Joins with SCB to help it Conquer Complexity in Building Fluid Infusion Systems that Maintain Precise Temperatures of Blood Products Exergen Global today announced that its Micro IRt/c-HB infrared non-contact sensors are being used to measure blood product… Click here to read the full article.

By |2019-03-12T20:07:05+00:00November 2nd, 2018|News|Comments Off on Exergen’s Sensors Help Develop A Solution To Ensure Safe Blood Transfusions

University Medical Centre Groningen Chooses TAT-5000 of Exergen Medical as Standard Thermometer Throughout The Hospital

University Medical Centre Groningen has decided to standardize on the TAT-5000 thermometer of Exergen Medical. The well-known university hospital – based in Groningen, The Netherlands – will buy several hundreds of the ‘temporal scanner’ from the Dutch distributor, Van Vliet Medical Products. Click here to read the full article.

By |2019-03-12T20:08:33+00:00November 2nd, 2018|News|Comments Off on University Medical Centre Groningen Chooses TAT-5000 of Exergen Medical as Standard Thermometer Throughout The Hospital